193 related articles for article (PubMed ID: 35275900)
1. Role of albumin in the treatment of decompensated liver cirrhosis.
Trebicka J
Curr Opin Gastroenterol; 2022 May; 38(3):200-205. PubMed ID: 35275900
[TBL] [Abstract][Full Text] [Related]
2. Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.
Arroyo V; Colmenero J
Dig Liver Dis; 2003 Sep; 35(9):668-72. PubMed ID: 14563192
[TBL] [Abstract][Full Text] [Related]
3. [News for usage of albumin in patients with liver disease].
Cremonese C; Uschner FE; Trebicka J
Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
[TBL] [Abstract][Full Text] [Related]
4. Albumin administration in patients with cirrhosis: Current role and novel perspectives.
de Mattos ÂZ; Simonetto DA; Terra C; Farias AQ; Bittencourt PL; Pase THS; Toazza MR; de Mattos AA;
World J Gastroenterol; 2022 Sep; 28(33):4773-4786. PubMed ID: 36156923
[TBL] [Abstract][Full Text] [Related]
5. Albumin: Indications in chronic liver disease.
Tufoni M; Zaccherini G; Caraceni P; Bernardi M
United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
[TBL] [Abstract][Full Text] [Related]
6. [The use of albumin infusion in decompensated liver cirrhosis].
Schmidt LE; Ring-Larsen H
Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
[TBL] [Abstract][Full Text] [Related]
7. Current indications for the use of albumin in the treatment of cirrhosis.
Alves de Mattos A
Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
[TBL] [Abstract][Full Text] [Related]
8. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
;
Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
[TBL] [Abstract][Full Text] [Related]
9. Clinical indications for the albumin use: still a controversial issue.
Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
[TBL] [Abstract][Full Text] [Related]
10. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Longo N; Panella C; Ierardi E
Curr Drug Saf; 2011 Sep; 6(4):267-74. PubMed ID: 22129322
[TBL] [Abstract][Full Text] [Related]
11. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc.
Grüngreiff K; Gottstein T; Reinhold D; Blindauer CA
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836265
[TBL] [Abstract][Full Text] [Related]
12. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
13. Position statement on the use of albumin in liver cirrhosis.
Castro-Narro G; Moctezuma-Velázquez C; Male-Velázquez R; Trejo-Estrada R; Bosques FJ; Moreno-Alcántar R; Rodríguez-Hernández H; Bautista-Santos A; Córtez-Hernández C; Cerda-Reyes E; Pérez-Escobar J; Aldana-Ledesma JM; Aguirre-Valadez J; Ruiz-Velasco JAV; Contreras-Omaña R; Miranda-Zazueta G; Reyes-Bastidas MDR; Meza-Cardona JM; Chávez-Tapia N; Fernández-Pérez NJ; García-Jiménez ES; Torre A
Ann Hepatol; 2022; 27(4):100708. PubMed ID: 35550187
[TBL] [Abstract][Full Text] [Related]
14. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
15. Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative?
Burroughs AK
Dig Liver Dis; 2003 Sep; 35(9):664-7. PubMed ID: 14563191
[TBL] [Abstract][Full Text] [Related]
16. Effect of low dose albumin administration in spontaneous bacterial peritonitis on renal function and survival.
Elloumi H; Sabbah M; Bibani N; Trad D; Elleuch N; Gargouri D; Ouakaa A; Kharrat J
Arab J Gastroenterol; 2019 Dec; 20(4):205-208. PubMed ID: 31759874
[TBL] [Abstract][Full Text] [Related]
17. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
18. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
19. Role of albumin infusion in cirrhosis-associated complications.
Heybe MA; Mehta KJ
Clin Exp Med; 2024 Mar; 24(1):58. PubMed ID: 38551716
[TBL] [Abstract][Full Text] [Related]
20. Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.
Zheng X; Bai Z; Wang T; Romeiro FG; Mancuso A; Philips CA; Wong YJ; Nery FG; Qi X
Adv Ther; 2023 Apr; 40(4):1494-1529. PubMed ID: 36697778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
